Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Casopitant

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Casopitant?

Casopitant is an investigational drug.

There have been 13 clinical trials for Casopitant. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2006.

The most common disease conditions in clinical trials are Vomiting, Nausea, and Postoperative Nausea and Vomiting. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].

Recent Clinical Trials for Casopitant
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic ChemotherapyGlaxoSmithKlinePhase 3
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.GlaxoSmithKlinePhase 3
The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in SubjectsGlaxoSmithKlinePhase 1

See all Casopitant clinical trials

Clinical Trial Summary for Casopitant

Top disease conditions for Casopitant
Top clinical trial sponsors for Casopitant

See all Casopitant clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.